How to Put Risk-Based CQV Strategies Into Practice (Even When Your Project Is Already Moving)
Everyone agrees that risk-based CQV (Commissioning, Qualification, and Validation) strategies are the modern, efficient path forward.
But for teams already in the trenches of a project, the shift feels unrealistic. With timelines accelerating, budgets shrinking, and legacy expectations pressing in, how can you apply a risk-based approach without starting over?
The good news: You don’t have to. This article outlines five practical steps for integrating risk-based CQV strategies into active projects, with real-world tactics and globally accepted guidance. It also builds on the key principles covered in our foundational blog post, “How Can Risk-Based CQV Services Boost Efficiency and Ensure Compliance Fast?”
If your team is looking to reduce overqualification, modernize your approach, or defend your validation decisions with confidence, this article is your next step forward.
Step 1: Anchor Everything in the URS
Your User Requirement Specification (URS) isn’t just a document: It’s your strategic compass for building defensible, risk-based CQV strategies. Too often, URSs are either missing, overly vague, or bloated with unnecessary expectations. A high-impact URS should:
Define intended use in language that aligns engineering with QA and business needs.
Prioritize critical functions over “nice-to-haves”.
Serve as the basis for risk assessment, qualification testing, and audit traceability.
According to ISPE Baseline Guide Vol. 5 (Second Edition), the URS is not only the foundation for traceability across design and qualification, but it’s also the best opportunity to embed Quality Risk Management (QRM) principles early, before complexity and assumptions take over.
"Without a clear URS, risk assessments and qualification activities become subjective and misaligned"
ISPE Baseline Guide, Vol. 5, 2021
A well-structured URS is not just a starting point: It’s a strategic tool that enables right-sized validation and supports lifecycle control.
Step 2: Apply a Practical Risk Assessment
Risk assessments in CQV often fall into the trap of being too theoretical or disconnected from actual system use. To move beyond formality, teams must adopt actionable, context-specific risk assessments that drive real qualification decisions.
Apply ICH Q9 (R1) principles to assess risk in terms of:
Product quality
Patient safety
Data integrity
Don’t stop at identifying risk; characterize it. Focus on severity, likelihood, and uncertainty to determine where controls are most needed and what level of qualification is appropriate. Risk scoring should inform, not replace, professional judgment.
From cross-functional teams that include engineering, validation, QA, and system owners. This diversity strengthens risk assessments with real operational insight.
Strong risk assessments shape smarter protocols. They help you allocate effort where it matters, reduce unnecessary testing, and provide a clear rationale regulators can follow.
Validation isn’t about doing more: It’s about making every action count.
"Risk assessments should be dynamic tools that guide decision-making, not checklists for regulatory optics"
ICH Q9 (R1), 2023
Step 3: Right-Size Qualification Efforts Using GEP
Right-sizing doesn’t mean cutting corners: It means leveraging Good Engineering Practice (GEP) principles to design quality into your systems and avoid redundant qualification.
According to ISPE and FDA guidance:
Use vendor documentation (FAT/SAT) and commissioning records as credible input.
Reserve full qualification (IQ/OQ/PQ) for GMP-critical components and critical design elements.
Use a risk-based approach to define the scope and depth of qualification, focusing on critical aspects and design elements that impact product quality and patient safety.
A seasoned CQV strategy integrates testing activities with design milestones, reducing duplication and delivering faster, defensible results.
Remember: GEP isn’t an escape from qualification, it’s a path to smarter, evidence-based control.
"Qualification activities should be scientifically justified and risk-based"
FDA Process Validation Guidance, 2011
Step 4: Integrate Documentation and Change Control Early
Many teams treat documentation as a post-project scramble. Instead, make traceability visible from the beginning:
Create a Traceability Matrix linking URS > Risk > Testing > Results.
Log change requests and deviations in real time.
Align qualification deliverables to a document hierarchy that shows structure and intention.
Proactive documentation supports continuous inspection readiness and reduces the fire drills that plague most CQV closeouts.
"Good documentation practices ensure transparency and support data integrity throughout the CQV lifecycle"
WHO Technical Report Series 996, Annex 5
Step 5: Make It Audit-Ready, Not Just Audit-Proof
Audit-readiness is a mindset, not a binder count. It’s about telling a story of control, from concept to qualification.
True audit-ready systems:
Present a logical chain of evidence from requirement to result.
Articulate the rationale behind every decision made.
Showcase consistent, accessible documentation that supports traceability.
Maintain a high-level “CQV storyboard” or executive summary that distills key elements for reviewers. Bonus: It doubles as a training tool for new team members or regulators unfamiliar with your process.
Successful risk-based CQV strategies are built on defensibility, traceability, and continuous improvement, not on volume.
Conclusion: Start Where You Are
Risk-based CQV strategies aren’t just for greenfield builds or ideal timelines. You can begin wherever you are by reframing how you qualify, what you test, and why it matters. Even with ongoing projects, meaningful improvements are possible. Start small, realign your URS, re-scope one system, or simplify your testing strategy, and build momentum.
Modern CQV is not a document factory, but a framework for smart, risk-justified decisions that support quality and compliance.
Remember: risk-based doesn’t mean risk-free. It means risk-focused.
References
ISPE Baseline Guide Vol. 5: Commissioning and Qualification (Second Edition), 2021
ICH Q9 (R1): Quality Risk Management, 2023
FDA Guidance for Industry: Process Validation: General Principles and Practices, 2011
WHO Technical Report Series No. 996, Annex 5: Supplementary guidelines on good manufacturing practices: validation, 2016
Ready to Put Risk-Based CQV Strategies into Practice, Even Mid-Project?
You don’t need a clean slate to take a smarter approach. Whether you’re in the middle of a commissioning effort or stuck in outdated validation cycles, Ellab can help you apply risk-based CQV with confidence.
Validation
